Phyto Therapy - Omega '3' MLC Fish Oil
Phyto Therapy Omega '3' MLC Fish Oil consists of Omega-3 fatty acids that may help with high blood pressure, heart disease, arthritis, breast cancer, psoriasis, eczema, weight loss, multiple sclerosis, brain function, and PMS.
The Omega '3' System is your Cardio and "Health Insurance" Program to be combined with:
- Proper Nutrition
- Recommended Nutritional Supplementation
Omega 3 (Fish Oil) and Diabetes
Although, there has been some controversy regarding the effect of omega-3 fatty acids in diabetes, scientific experts and research studies appear to support the use of fish oil supplementation for patients with type 2 diabetes, suggesting a positive effect on triglyceride levels and no adverse effect on glycemic control.
In a study investigating the effect of long-term administration of EPA-E (highly purified eicosapentaenoic acid ethyl ester), the incidence of diabetes was shown to be significantly suppressed at an EPA-E intake level of 0.3g/kg or higher. Furthermore, administration of EPA-E was shown to decrease the elevation of plasma glucose after an oral glucose load and ameliorate coagulation-related parameters. In addition, ADP (collagen-induced platelet aggregation) and the cholesterol to phospholipids (C/P) molar ratio in platelet membranes were both suppressed at an EPA-E dose of 0.1 g/kg or higher.
According to some researchers omega-3 fatty acids may improve many of the adverse metabolic effects of insulin resistance by lowering blood pressure and triacylglycerol concentrations. Administration of EPA-E (1800 mg/day for 48 weeks) to patients with type 2 diabetes mellitus resulted in significant beneficial effects on diabetic neuropathy and serum lipids as well as other diabetic complications such as nephropathy and macroangiopathy. EPA-E was found to improve clinical symptoms (coldness, numbness), the vibration perception threshold sense of the lower extremities, and significantly decrease serum triglycerides as well as excretion f albumin in urine.
Omega-3 and Alzheimer's
A recent study published in July 2003 in Archives of Neurology showed that people who ate Omega 3 rich fish such as salmon once a week or more had a substantially lower risk of Alzheimer's disease. In fact, the seven-year study of 815 nursing home residents found those who reported eating fish at least once a week had a 60 percent lower risk of Alzheimer's compared to those who rarely or never ate fish.
This new finding is in sync with a growing body of scientific evidence that suggests people can reduce their risk of developing a number of killer diseases, such as heart disease, cancer and now Alzheimer's, if they ate a healthier diet - one rich in Omega 3 oils from fish, plus plenty of fresh fruits and vegetables.
In an accompanying editorial, Robert Friedland, M.D. of Case Western Reserve University School of Medicine in Cleveland, Ohio, said a healthy diet containing fish could help ward off a host of ailments, not just Alzheimer's, though he warned of toxins such as mercury tainting some fish.
Most health experts agree that eating fish high in Omega 3 is a good idea, but they also warn that some people, particularly pregnant women and young children, should avoid fish high in methyl mercury, a harmful contaminant found in some fish. Swordfish, shark, tuna and other large predatory fish can contain lots of mercury, while salmon, flounder and cod generally do not have as much.
Lupus and Omega 3 Fish Oil
In a recent 6 month study, Dr. Emeir Duffy from the School of Biomedical Sciences at the University of Ulster studied the effect of fish oil supplements in 52 lupus patients.
The results are promising for sufferers of this disorder in which the immune system attacks healthy tissue throughout the body, causing painful or swollen joints, unexplained fever, skin rashes, kidney problems, cardiovascular complications and extreme fatigue.
Systemic lupus erythematosus--commonly referred to as lupus—is a complex disease and the exact cause is unclear. Unfortunately, there are currently no effective treatments to stop its progression. Steroids and other drugs are used to manage symptoms, but, many health care professionals believe that steroids should be administered for the shortest period of time possible to reduce their un-wanted side-effects. Therefore, clinical researchers have recently been looking at attempting to manage symptoms of the disease through diet. The omega-3 fatty acids found in fish oils are of real interest because they are thought to fight inflammation and affect immune function.
Participants in the study took either fish-oil supplements three times per day, a copper supplement, copper plus fish oil or a placebo. Duffy's team found that the copper was of no benefit. But, all the participants who took the fish oil saw improvements in quality of life, inflammation and fatigue, which is one of the most debilitating symptoms of lupus.
Depression, Bipolar Disorder and Omega 3
More than 20 million children and adults in the U.S. are affected by major depression or bipolar disorder, and depression has been shown to be a leading cause of disability worldwide. In recognition of the scope and burden of these serious medical illnesses, The National Institute of Mental Health, (NIMH), a U.S. Government Agency, launched a major effort to assess our current knowledge and to plan a course of research that will move the Nation ahead in answering unsolved questions related to mood disorders.
To accomplish the task of reviewing the science and recommending how to spur scientific progress, NIMH convened nine scientific workgroups in January 2001. The groups spanned the breadth of the relevant science, from genetics to clinical trials and psychosocial interventions, to research that examines the service system and obstacles to care. The workgroups were comprised of nationally recognized scientific experts, members of the National Advisory Mental Health Council, representatives of consumer and advocacy groups, and NIMH staff.
One of the experts writing and speaking on this subject was Joseph R. Hibbeln, M.D. who wrote the following article on March 8, 2002 on Omega 3 and its emerging protective role as a potential treatment for borderline personality disorders.
Emerging protective roles for omega-3 fatty acids in affective and aggressive disorders. A potential treatment for borderline personality disorders?
Recent data from epidemiological studies and placebo controlled intervention trials in affective and aggressive disorders suggest that omega-3 essential fatty acids may have a role in the therapy of borderline personality disorder since these conditions have several common features. Although the idea that the dietary intake of polyunsaturated fatty acids could be efficacious in this disorder may seem unusual, it should be pointed out that their importance have already been widely recognized in major illnesses including heart disease, cancers, rheumatoid arthritis and diabetes. Despite the observation that the majority of the brain is comprised of lipids and fatty acids, the examination of the role of lipids and fatty acids in psychiatric disorders is still in its infancy. Of particular interest are two polyunsaturated essential fatty acids: docosahexaenoic acid (DHA) and arachidonic acid (AA), which are selectively concentrated in synaptic neuronal membranes and thought to be necessary for optimal neurodevelopment. These fatty acids, and their precursors, cannot be made de novo and are available only from dietary sources such as seafood, which is a rich source of DHA and other omega-3 fatty acids such as eicosapentaenoic acid (EPA). Disorders with affective and/or impulsive features appear to be responsive to greater omega-3 fatty acid intake. In cross-national analyses, greater seafood consumption has been associated with lower prevalence rates of major depression across a 50-fold range, lower prevalence rates of bipolar disorders across a 30-fold range, and lower rates of homicide mortality across a 20-fold range. Randomized, double-blind, placebo-controlled trials of mixtures of DHA and EPA or of EPA alone have documented robust responses in bipolar disorder, treatment resistant depression (two trials) and in reducing measures of hostility and aggression. Since patients with borderline personality disorder frequently have concurrent affective and impulsive features, but respond poorly to most medications, omega-3 fatty acids can be explored as a potential treatment alternative.